Femasys company info

What does Femasys do?
Femasys (NASDAQ:FEMY) is a biotechnology firm focused on developing innovative solutions for women's healthcare, particularly in areas of reproductive health. The company is committed to advancing a portfolio of products and technologies aimed at filling significant gaps in women's health, particularly in fertility and contraceptive solutions. Femasys is dedicated to improving the availability and efficacy of treatments and diagnostics for women globally, with ongoing projects that include non-surgical, in-office procedures for infertility and permanent birth control. The primary objective of Femasys is to transform women's healthcare by offering less invasive, more accessible, and patient-friendly medical options, empowering women to take control of their health decisions.
Femasys company media
Company Snapshot

Is Femasys a public or private company?

key
Ownership
Public

How many people does Femasys employ?

people
Employees
33

What sector is Femasys in?

pie chart
Sector
Health Care

Where is the head office for Femasys?

location pin
Head Office
Suwanee, United States

What year was Femasys founded?

founded flag
Year Founded
2004
What does Femasys specialise in?
/Medical Devices /Women's Health /Fertility Solutions /Contraceptive Technologies /Clinical Trials /Patient Services

What are the products and/or services of Femasys?

Overview of Femasys offerings
"FemBloc permanent birth control, a non-surgical, in-office solution providing women a permanent birth control option without hormones or invasive surgery."
"FemaSeed localized directional insemination, a revolutionary assisted reproductive technology aimed at enhancing the success rates of conception in a simpler, less invasive manner."
"FemCerv endocervical tissue sampler, a device designed for the collection of tissue samples from the cervical canal, improving the accuracy and efficiency of cervical health assessments."
"FemEMB endometrial tissue sampler, a product aimed at simplifying the process of obtaining endometrial tissue samples for diagnostic purposes, ensuring minimal discomfort and increased patient compliance."
"FemCheck, an early-stage development project for at-home diagnostics, focusing on female reproductive health to enhance accessibility and convenience for women monitoring their fertility and reproductive health."

Who is in the executive team of Femasys?

Femasys leadership team
  • Ms. Kathy  Lee-Sepsick M.B.A.
    Ms. Kathy Lee-Sepsick M.B.A.
    Founder, President, CEO & Director
  • Mr. Dov  Elefant
    Mr. Dov Elefant
    Chief Financial Officer
  • Mr. Daniel Scott Currie
    Mr. Daniel Scott Currie
    COO, Senior VP & Secretary
  • Ms. Mary An Merchant J.D., Ph.D.
    Ms. Mary An Merchant J.D., Ph.D.
    Vice President of Counsel & Intellectual Property
  • Dr. Jeffrey  Marcus M.D., M.S.
    Dr. Jeffrey Marcus M.D., M.S.
    Chief Medical Advisor
  • Ms. Christine  Thomas
    Ms. Christine Thomas
    Senior VP of Regulatory & Clinical Affairs
  • Dr. James H. Liu M.D.
    Dr. James H. Liu M.D.
    Chief Medical Officer
  • Mr. Richard  Spector
    Mr. Richard Spector
    Chief Commercial Officer